Ahmadzadeh ELF (2017) Paclitaxel resistance in triple negative breast cancer involves novel functional genomic aberrations in the ABCB1 gene. GSE90564

Ahn S, Park JH, Grimm SL, Piyarathna DWB, Samanta T, Putluri V, Mezquita D, Fuqua SAW et al (2024) Metabolomic rewiring promotes endocrine therapy resistance in breast cancer. Cancer Res 84(2):291–304. https://doi.org/10.1158/0008-5472.Can-23-0184

Alves CL, Ditzel HJ (2023) Drugging the PI3K/AKT/mTOR pathway in ER+ breast cancer. Int J Mol Sci 24(5):4522. https://doi.org/10.3390/ijms24054522

Barkovskaya A, Seip K, Prasmickaite L, Mills IG, Moestue SA, Itkonen HM (2020) Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells. Sci Rep 10(1):16992. https://doi.org/10.1038/s41598-020-74083-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH et al (2013) NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res 41(Database issue):D991–D995. https://doi.org/10.1093/nar/gks1193

Bartha Á, Győrffy B (2021) TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. https://doi.org/10.3390/ijms22052622

Article  PubMed  PubMed Central  Google Scholar 

Bayram OYCA (2024) Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer. GSE262353

Braunstein M, Liao L, Lyttle N, Lobo N, Taylor KJ, Krzyzanowski PM, Kalatskaya I, Yao CQ et al (2016) Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer. Breast Cancer Res 18(1):16. https://doi.org/10.1186/s13058-016-0676-6

Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS et al (2022) Ualcan: an update to the integrated cancer data analysis platform. Neoplasia 25:18–27. https://doi.org/10.1016/j.neo.2022.01.001

Chapman BV, Wald AI, Akhtar P, Munko AC, Xu J, Gibson SP, Grandis JR, Ferris RL et al (2015) Microrna-363 targets myosin 1B to reduce cellular migration in head and neck cancer. BMC Cancer 15(1):861. https://doi.org/10.1186/s12885-015-1888-3

Coluccio LM, Geeves MA (1999) Transient kinetic analysis of the 130-kDa myosin I (MYR-1 gene product) from rat liver: a myosin I designed for maintenance of tension? J Biol Chem 274(31):21575–21580. https://doi.org/10.1074/jbc.274.31.21575

Article  CAS  PubMed  Google Scholar 

Cordonnier MN, Dauzonne D, Louvard D, Coudrier E (2001) Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes. Mol Biol Cell 12(12):4013–4029. https://doi.org/10.1091/mbc.12.12.4013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG et al (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403):346–352. https://doi.org/10.1038/nature10983Accessed

Diz-Muñoz A, Krieg M, Bergert M, Ibarlucea-Benitez I, Muller DJ, Paluch E, Heisenberg CP et al (2010) Control of directed cell migration in vivo by membrane-to-cortex attachment. PLoS Biol 8(11):e1000544. https://doi.org/10.1371/journal.pbio.1000544

Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533–1537. https://doi.org/10.1136/bmj.315.7121.1533

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elias D, Vever H, Lænkholm AV, Gjerstorff MF, Yde CW, Lykkesfeldt AE, Ditzel HJ et al (2015) Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Oncogene 34(15):1919–1927. https://doi.org/10.1038/onc.2014.138

Fekete JT, Győrffy B (2019) ROCplot.org: validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer 145(11):3140–3151. https://doi.org/10.1002/ijc.32369

Article  CAS  PubMed  Google Scholar 

Feng M, Santhanam RK, Xing H, Zhou M, Jia H (2024) Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance. Biochem Pharmacol 220:115991. https://doi.org/10.1016/j.bcp.2023.115991

Article  CAS  PubMed  Google Scholar 

Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S, Mihai R, Bisio A et al (2024) Novel treatment strategies for hormone receptor (HR)-positive, HER2-negative metastatic breast cancer. J Clin Med. https://doi.org/10.3390/jcm13123611

Fokkens WJ (2019) The advantage of sytematic reviews and meta-analysis. Rhinology 57(6):401. https://doi.org/10.4193/Rhin19.406

Article  CAS  PubMed  Google Scholar 

Foutadakis S, Kordias D, Vatsellas G, Magklara A (2024) Identification of new chemoresistance-associated genes in triple-negative breast cancer by single-cell transcriptomic analysis. Int J Mol Sci. https://doi.org/10.3390/ijms25136853

Article  PubMed  PubMed Central  Google Scholar 

Geeves MA, Perreault-Micale C, Coluccio LM (2000) Kinetic analyses of a truncated mammalian myosin I suggest a novel isomerization event preceding nucleotide binding. J Biol Chem 275(28):21624–21630. https://doi.org/10.1074/jbc.M000342200

Article  CAS  PubMed  Google Scholar 

Gholami A (2024) Cancer stem cell-derived exosomes in CD8(+) T cell exhaustion. Int Immunopharmacol 137:112509. https://doi.org/10.1016/j.intimp.2024.112509

Article  CAS  PubMed  Google Scholar 

Glaviano A, Wander SA, Baird RD, Yap KC, Lam HY, Toi M, Carbone D, Geoerger B et al (2024) Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment. Drug Resist Updat. 76:101103. https://doi.org/10.1016/j.drup.2024.101103

Gonzalez-Malerva L, Park J, Zou L, Hu Y, Moradpour Z, Pearlberg J, Sawyer J, Stevens H et al (2011) High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA 108(5):2058–2063. https://doi.org/10.1073/pnas.1018157108

Gu L, Lau SK, Loera S, Somlo G, Kane SE (2009) Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines. Clin Cancer Res 15(23):7196–7206. https://doi.org/10.1158/1078-0432.Ccr-09-0585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harris MA, Savas P, Virassamy B, O'Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R et al (2024) Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer 24(8):554–577. https://doi.org/10.1038/s41568-024-00714-6

Jézéquel P, Gouraud W, Ben Azzouz F, Guérin-Charbonnel C, Juin PP, Lasla H et al (2021) bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database (Oxford). https://doi.org/10.1093/database/baab007

Jones CJSM (2021) Development and characterization of a novel endoxifen-resistant breast cancer cell line highlights numerous differences from tamoxifen-resistant models. GSE164529

Jung H, Paust S (2024) Chemokines in the tumor microenvironment: implications for lung cancer and immunotherapy. Front Immunol 15:1443366. https://doi.org/10.3389/fimmu.2024.1443366

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan IR, Sadida HQ, Hashem S, Singh M, Macha MA, Al-Shabeeb Akil AS, Khurshid I, Bhat AA et al (2024) Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer. Biomed Pharmacother 176:116873. https://doi.org/10.1016/j.biopha.2024.116873

Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, Fulton LL, Dooling DJ et al (2012) Comprehensive molecular portraits of human breast tumours. Nature. 490(7418):61–70. https://doi.org/10.1038/nature11412

Lanceta L, Lypova N, O'Neill C, Li X, Rouchka E, Chesney J, Imbert-Fernandez Y et al (2021) Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq. Breast Cancer Res Treat 186(3):677–686. https://doi.org/10.1007/s10549-021-06127-5

Li S-H, Qian L, Chen Y-H, Lu H-I, Tsai H-T, Lyu H, Yang R, Chen C-H et al (2022) Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma. J Cell Physiol 237(9):3671–3686. https://doi.org/10.1002/jcp.30831

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48(W1):W509–W514. https://doi.org/10.1093/nar/gkaa407

Navarro-Yepes J, Kettner NM, Rao X, Bishop CS, Bui TN, Wingate HF, Singareeka Raghavendra A, Wang Y et al (2023) Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers. Cancer Res 83(19):3264–3283. https://doi.org/10.1158/0008-5472.Can-23-0705

Ngambenjawong C, Gustafson HH, Pun SH (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206–221. https://doi.org/10.1016/j.addr.2017.04.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nunnery SE, Mayer IA (2020) Targeting the PI3K/AKT/mTOR pathway in hormone-positive breast cancer. Drugs 80(16):1685–1697. https://doi.org/10.1007/s40265-020-01394-w

Oliveira G, Wu CJ (2023) Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer 23(5):295–316. https://doi.org/10.1038/s41568-023-00560-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ortega MA, Boaru DL, De Leon-Oliva D, Fraile-Martinez O, García-Montero C, Rios L, Garrido-Gil MJ, Barrena-Blázquez S et al (2024) PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications. J Mol Med (Berl) 102(8):987–1000. https://doi.org/10.1007/s00109-024-02463-3

Pancholi S, Ribas R, Simigdala N, Schuster E, Nikitorowicz-Buniak J, Ressa A, Gao Q, Leal MF et al (2020) Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities. Oncogene 39(25):4781–4797. https://doi.org/10.1038/s41388-020-1284-6

Park J, Hsueh PC, Li Z, Ho PC (2023) Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity 56(1):32–42. https://doi.org/10.1016/j.immuni.2022.12.008

Article  CAS  PubMed  Google Scholar 

Park SJ, Yoon BH, Kim SK, Kim SY (2019) GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics 12(Suppl 5):101. https://doi.org/10.1186/s12920-019-0514-7

Article  PubMed  PubMed Central  Google Scholar 

Pérez-Pena J, Páez R, Nieto-Jiménez C, Sánchez VC, Galan-Moya EM, Pandiella A, Győrffy B, Ocana A et al (2019) Mapping bromodomains in breast cancer and association with clinical outcome. Sci Rep 9(1):5734. https://doi.org/10.1038/s41598-019-41934-3

Prospéri M-T, Lépine P, Dingli F, Paul-Gilloteaux P, Martin R, Loew D, Knölker H-J, Coudrier E et al (2015) Myosin 1b functions as an effector of EphB signaling to control cell repulsion. J Cell Biol 210(2):347–361. https://doi.org/10.1083/jcb.201501018

Rai A, Greening DW, Chen M, Xu R, Ji H, Simpson RJ (2019) Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics 19(8):e1800148. https://doi.org/10.1002/pmic.201800148

Article  CAS  PubMed  Google Scholar 

Raposo G, Cordonnier M-N, Tenza D, Menichi B, Durrbach A, Louvard D, Coudrier E et al (1999) Association of myosin I alpha with endosomes and lysosomes in mammalian cells. Mol Biol Cell 10(5):1477–1494

Ruppert C, Kroschewski R, Bähler M (1993) Identification, characterization and cloning of myr 1, a mammalian myosin-I. J Cell Biol 120(6):1393–1403. https://doi.org/10.1083/jcb.120.6.1393

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saal LH, Vallon-Christersson J, Häkkinen J, Hegardt C, Grabau D, Winter C, Brueffer C, Tang MH et al (2015) The Sweden cancerome analysis network - breast (SCAN-B) initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med 7(1):20. https://doi.org/10.1186/s13073-015-0131-9

Salas-Cortes L, Ye F, Tenza D, Wilhelm C, Theos A, Louvard D, Raposo G, Coudrier E et al (2005) Myosin Ib modulates the morphology and the protein transport within multi-vesicular sorting endosomes. J Cell Sci 118(Pt 20):4823–4832. https://doi.org/10.1242/jcs.02607

Sherman BT, Hao M, Qiu J, Jiao X, Basel